require_once "./_includes/constant.php"; ?>
Chulalongkorn Medical Journal aims to publish original peer-reviewed contributions related with various aspects in the biomedical and health sciences from experimental to clinical topics. Original research articles, short communications, review articles, case reports, and letter to editor are welcome.
The journal is supported by the Faculty of Medicine, Chulalongkorn University, who covers the cost of publication on behalf of the authors on acceptance of their article. Contemporary studies including basic research, clinical trials, studies of diagnostic accuracy, studies relating to behavioral, therapeutic, or epidemiological aspects of medicine, public health, environmental health, and health and social care are welcomed. We also welcome research from disciplines across the health sciences.
Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. More details about the peer review process can be found here.
Chulalongkorn Medical Journal operates a double-blind peer review system, where both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. It is the traditional model of peer review that many reviewers are comfortable with, and it facilitates an unbiased assessment of a manuscript.
Chulalongkorn Medical Journal is supported by an expert Editorial Board. All submitted manuscripts are evaluated by the Editor-in-Chief and appropriate manuscripts are then assigned to at least two reviewers for their comments. We make every effort to reach an initial decision within six weeks of submission. Based on the reviews, the Editor-in-Chief rejects, accepts or requests revisions of the manuscript.
All manuscripts submitted to the Chulalongkorn Medical Journal are first evaluated on the basis of scientific quality, originality, appropriateness, contribution to the field, and style. Suitable manuscripts are then subject to rigorous, fair, and rapid peer review.
Issues per year: Quarterly (10 - 15 articles per issue)
No.1 January - March
No.2 April - June
No.3 July - September
No.4 October - December
All articles published by the Chulalongkorn Medical Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. As authors of articles published in the Chulalongkorn Medical Journal, they are the copyright holders of their own article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate their article. Our authors retain copyright of their work through a Creative Commons attribution license that clearly states how readers can copy, distribute, and use their attributed research, free of charge.
The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing the research or interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems. Disclosure form shall be same with the International Committee of Medical Journal Editors (ICMJE) Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The Chulalongkorn Medical Journal asks referees to let its Editor know of any conflict of interest before reviewing a particular manuscript.
The journal adopts CC BY-NC-ND license for its content. Users are free to: